Rupeng Li, MD
Pain Medicine · Boston, MANPI 1508395690
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,925 of the $4,438 with a category attached, or 65.9%. 7 manufacturers reported payments, led by Abbott at 41.1% of the total. Reporting peaked in 2021 at $2,672 and has fallen 85.8% since, to $379 in 2025.
Across 43 payments — averaging $103.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Boston Scientific$934
- Medtronic$687
- Biotronik NRO, Inc.$612
- SPR Therapeutics, Inc$178
- Painteq LLC$163
- plus $39 from 1 others
What the payments were for
- Travel & lodging$1,51234%
- Food & beverage$2,92566%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 16 | $1,825 |
| Boston Scientific | 8 | $934 |
| Medtronic | 7 | $687 |
| Biotronik NRO, Inc. | 7 | $612 |
| SPR Therapeutics, Inc | 2 | $178 |
| Painteq LLC | 2 | $163 |
| Nevro Corp. | 1 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim DRG IPG$884
- INTELLIS ADAPTIVESTIM$574
- Prospera$547
- Proclaim IPG$545
- WAVEWRITER ALPHA$460
- WaveWriter Alpha Prime 16$292
- SPRINT PNS System$142
- PAINTEQ$122
How this compares
$4,438 in reported general payments places this provider in the 65th percentile of 137 pain medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 58 | $13,659 |
| BelbucaBuprenorphine Hcl | 13 | $11,231 |
| Pregabalin | 53 | $1,306 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 14 | $1,086 |
| Naloxone Hcl | 19 | $945 |
| Duloxetine Hcl | 69 | $903 |
| Gabapentin | 56 | $661 |
| Tizanidine Hcl | 47 | $395 |
| Baclofen | 24 | $331 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $275 |
| Cyclobenzaprine Hcl | 11 | $100 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Boston
- Thomas SimopoulosBoston$181K
- Arti OriBoston$62K
- Christine SangBoston$56K
- Eduard VaynbergBoston$32K
- David HaoBoston$16K
- Erika YihBoston$8K
- Samuel AngBoston$7K
- Kevin VuBoston$6K
- Brenda LeeBoston$6K
- Steven MachBoston$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.